Page 94 - Prostate News Today

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

More than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the disease remain unexplored for the majority of patients around the world.

Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly increase the risk of certain cancers such as ovarian, breast, pancreatic and prostate cancer.

Researchers investigated whether disparities in the presentation of late-stage prostate, lung, colorectal, and breast cancers associated with race were exacerbated during the coronavirus disease 2019 (COVID-19) pandemic.

Researchers investigate alterations in the semen microbiome before and after the vasectomy procedure.

​​​​BGI has currently published over 440 SCI (Science Citation Index) papers in the field of cancer research, with a cumulative impact factor of over 4,000 points.

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells.

Cancer Biomarkers & Pharmaceutical Companies Lining Up for Clinical Trials to Cater to Growing Demand, Pushing Sales Past US$ 11 Billion in 2022 In its latest report, Fact.MR presents an

Emory researchers are on the cusp of seeing in real time how brain diseases like Alzheimer's and autism spectrum disorder affect a patient's brain function.

When facing the trauma of prostate cancer, it is not unusual for men to think of the aftermath.